{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:22:55Z","timestamp":1792549375991,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02516-2","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:35:42Z","timestamp":1766050542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Targeting OxLDL-mediated CD36\u2009+\u2009CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Anyu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuangzhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"2516_CR1","doi-asserted-by":"publisher","unstructured":"Beird HC, Bielack SS, Flanagan AM, Gill J, Heymann D, Janeway KA, Livingston JA, Roberts RD, Strauss SJ, Gorlick R. Osteosarcoma. Nat Rev Dis Primer 2022;8:77. https:\/\/doi.org\/10.1038\/s41572-022-00409-y.","DOI":"10.1038\/s41572-022-00409-y"},{"key":"2516_CR2","doi-asserted-by":"publisher","unstructured":"Yu S, Yao X. Advances on immunotherapy for osteosarcoma. Mol Cancer 2024;23:192. https:\/\/doi.org\/10.1186\/s12943-024-02105-9.","DOI":"10.1186\/s12943-024-02105-9"},{"key":"2516_CR3","doi-asserted-by":"publisher","unstructured":"Wu B, Zhang B, Li B, Wu H, Jiang M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther 2024;9:274. https:\/\/doi.org\/10.1038\/s41392-024-01979-x.","DOI":"10.1038\/s41392-024-01979-x"},{"key":"2516_CR4","doi-asserted-by":"publisher","unstructured":"Wu C-C, Beird HC, Andrew Livingston J, Advani S, Mitra A, Cao S, Reuben A, Ingram D, Wang W-L, Ju Z, Hong Leung C, Lin H, Zheng Y, Roszik J, Wang W, Patel S, Benjamin RS, Somaiah N, Conley AP, Mills GB, Hwu P, Gorlick R, Lazar A, Daw NC, Lewis V, Futreal PA. Immuno-genomic landscape of osteosarcoma. Nat Commun 2020;11:1008. https:\/\/doi.org\/10.1038\/s41467-020-14646-w.","DOI":"10.1038\/s41467-020-14646-w"},{"key":"2516_CR5","doi-asserted-by":"publisher","unstructured":"Luo T, Fan Z, Zeng A, Wang A, Pan Y, Xu Y, Chen H, Chen W, Nie D, Lin J, Huang A, Gong M, Huang Y, Ding Y, Zhu X, Rao L, Wang J. Biomimetic Targeted Co-Delivery System Engineered from Genomic Insights for Precision Treatment of Osteosarcoma. Adv Sci n.d.;n\/a:2410427. https:\/\/doi.org\/10.1002\/advs.202410427.","DOI":"10.1002\/advs.202410427"},{"key":"2516_CR6","doi-asserted-by":"publisher","unstructured":"Zhang F, Ma Y, Li D, Wei J, Chen K, Zhang E, Liu G, Chu X, Liu X, Liu W, Tian X, Yang Y. Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution. J Hematol OncolJ Hematol Oncol 2024;17:80. https:\/\/doi.org\/10.1186\/s13045-024-01600-2.","DOI":"10.1186\/s13045-024-01600-2"},{"key":"2516_CR7","doi-asserted-by":"publisher","unstructured":"Chhabra Y, Weeraratna AT. Fibroblasts in cancer: Unity in heterogeneity. Cell 2023;186:1580\u2013609. https:\/\/doi.org\/10.1016\/j.cell.2023.03.016.","DOI":"10.1016\/j.cell.2023.03.016"},{"key":"2516_CR8","doi-asserted-by":"publisher","unstructured":"Xu Y, Deng C, Chen H, Song Y, Xu H, Song G, Wang X, Luo T, Chen W, Ma J, Zeng A, Huang S, Chen Z, Fu J, Gong M, Tai Y, Huang A, Feng H, Hu J, Zhu X, Tang Q, Lu J, Wang J. Osteosarcoma Cells Secrete CXCL14 That Activates Integrin \u03b111\u03b21 on Fibroblasts to Form a Lung Metastatic Niche. Cancer Res 2024;84:994\u20131012. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-1307.","DOI":"10.1158\/0008-5472.CAN-23-1307"},{"key":"2516_CR9","doi-asserted-by":"publisher","unstructured":"Liang T, Tao T, Wu K, Liu L, Xu W, Zhou D, Fang H, Ding Q, Huang G, Wu S. Cancer-Associated Fibroblast-Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer. Adv Sci Weinh Baden-Wurtt Ger 2023;10:e2303230. https:\/\/doi.org\/10.1002\/advs.202303230.","DOI":"10.1002\/advs.202303230"},{"key":"2516_CR10","doi-asserted-by":"publisher","unstructured":"Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, Lameiras S, Albergante L, Bonneau C, Guyard A, Tarte K, Zinovyev A, Baulande S, Zalcman G, Vincent-Salomon A, Mechta-Grigoriou F. Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer. Cancer Discov 2020;10:1330\u201351. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1384.","DOI":"10.1158\/2159-8290.CD-19-1384"},{"key":"2516_CR11","doi-asserted-by":"publisher","unstructured":"Gan L, Lu T, Lu Y, Song H, Zhang J, Zhang K, Lu S, Wu X, Nie F, Di S, Han D, Yang F, Qin W, Wen W. Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8\u2009+\u2009T cell infiltration. J Immunother Cancer 2024;12:e009111. https:\/\/doi.org\/10.1136\/jitc-2024-009111.","DOI":"10.1136\/jitc-2024-009111"},{"key":"2516_CR12","doi-asserted-by":"publisher","unstructured":"13. Yu W, Lei Q, Yang L, Qin G, Liu S, Wang D, Ping Y, Zhang Y. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. J Hematol OncolJ Hematol Oncol 2021;14:187. https:\/\/doi.org\/10.1186\/s13045-021-01200-4.","DOI":"10.1186\/s13045-021-01200-4"},{"key":"2516_CR13","doi-asserted-by":"publisher","unstructured":"Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun Lond Engl 2018;38:27. https:\/\/doi.org\/10.1186\/s40880-018-0301-4.","DOI":"10.1186\/s40880-018-0301-4"},{"key":"2516_CR14","doi-asserted-by":"publisher","unstructured":"Xu S, Chaudhary O, Rodr\u00edguez-Morales P, Sun X, Chen D, Zappasodi R, Xu Z, Pinto AFM, Williams A, Schulze I, Farsakoglu Y, Varanasi SK, Low JS, Tang W, Wang H, McDonald B, Tripple V, Downes M, Evans RM, Abumrad NA, Merghoub T, Wolchok JD, Shokhirev MN, Ho P-C, Witztum JL, Emu B, Cui G, Kaech SM. Uptake of oxidized lipids from the tumor microenvironment by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8 T cells. Immunity 2021;54:1561\u20131577.e7. https:\/\/doi.org\/10.1016\/j.immuni.2021.05.003.","DOI":"10.1016\/j.immuni.2021.05.003"},{"key":"2516_CR15","doi-asserted-by":"publisher","unstructured":"Li Z, Sun C, Qin Z. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming. Theranostics 2021;11:8322\u201336. https:\/\/doi.org\/10.7150\/thno.62378.","DOI":"10.7150\/thno.62378"},{"key":"2516_CR16","doi-asserted-by":"publisher","unstructured":"Zhu G-Q, Tang Z, Huang R, Qu W-F, Fang Y, Yang R, Tao C-Y, Gao J, Wu X-L, Sun H-X, Zhou Y-F, Song S-S, Ding Z-B, Dai Z, Zhou J, Ye D, Wu D-J, Liu W-R, Fan J, Shi Y-H. CD36\u2009+\u2009cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell Discov 2023;9:25. https:\/\/doi.org\/10.1038\/s41421-023-00529-z.","DOI":"10.1038\/s41421-023-00529-z"},{"key":"2516_CR17","doi-asserted-by":"publisher","unstructured":"Zhang Y, Gu Z, Wan J, Lou X, Liu S, Wang Y, Bian Y, Wang F, Li Z, Qin Z. Stearoyl-CoA Desaturase-1 dependent lipid droplets accumulation in cancer-associated fibroblasts facilitates the progression of lung cancer. Int J Biol Sci 2022;18:6114\u201328. https:\/\/doi.org\/10.7150\/ijbs.74924.","DOI":"10.7150\/ijbs.74924"},{"key":"2516_CR18","doi-asserted-by":"publisher","unstructured":"Zhou Y, Yang D, Yang Q, Lv X, Huang W, Zhou Z, Wang Y, Zhang Z, Yuan T, Ding X, Tang L, Zhang J, Yin J, Huang Y, Yu W, Wang Y, Zhou C, Su Y, He A, Sun Y, Shen Z, Qian B, Meng W, Fei J, Yao Y, Pan X, Chen P, Hu H. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. Nat Commun 2020;11:6322. https:\/\/doi.org\/10.1038\/s41467-020-20059-6.","DOI":"10.1038\/s41467-020-20059-6"},{"key":"2516_CR19","doi-asserted-by":"publisher","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 2021;20:131. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","DOI":"10.1186\/s12943-021-01428-1"},{"key":"2516_CR20","doi-asserted-by":"publisher","unstructured":"Assouline B, Kahn R, Hodali L, Condiotti R, Engel Y, Elyada E, Mordechai-Heyn T, Pitarresi JR, Atias D, Steinberg E, Bidany-Mizrahi T, Forkosh E, Katz LH, Benny O, Golan T, Hofree M, Stewart SA, Atlan KA, Zamir G, Stanger BZ, Berger M, Ben-Porath I. Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8\u2009+\u2009T cell activation and limit responsiveness to immunotherapy in mice. Nat Commun 2024;15:6162. https:\/\/doi.org\/10.1038\/s41467-024-50441-7.","DOI":"10.1038\/s41467-024-50441-7"},{"key":"2516_CR21","doi-asserted-by":"publisher","unstructured":"Xiong Z, Chan SL, Zhou J, Vong JSL, Kwong TT, Zeng X, Wu H, Cao J, Tu Y, Feng Y, Yang W, Wong PP-C, Si-Tou WW-Y, Liu X, Wang J, Tang W, Liang Z, Lu J, Li KM, Low J-T, Chan MW-Y, Leung HHW, Chan AWH, To K-F, Yip KY-L, Lo YMD, Sung JJ-Y, Cheng AS-L. Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma. Gut 2023;72:1758\u201373. https:\/\/doi.org\/10.1136\/gutjnl-2022-328364.","DOI":"10.1136\/gutjnl-2022-328364"},{"key":"2516_CR22","doi-asserted-by":"publisher","unstructured":"Yang P-B, Hou P-P, Liu F-Y, Hong W-B, Chen H-Z, Sun X-Y, Li P, Zhang Y, Ju C-Y, Luo L-J, Wu S-F, Zhou J-X, Wang Z-J, He J-P, Li L, Zhao T-J, Deng X, Lin T, Wu Q. Blocking PPAR\u03b3 interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression. Proc Natl Acad Sci U S A 2020;117:27412\u201322. https:\/\/doi.org\/10.1073\/pnas.2002997117.","DOI":"10.1073\/pnas.2002997117"},{"key":"2516_CR23","doi-asserted-by":"publisher","unstructured":"Hotamisligil GS, Bernlohr DA. Metabolic functions of FABPs\u2014 mechanisms and therapeutic implications. Nat Rev Endocrinol 2015;11:592\u2013605. https:\/\/doi.org\/10.1038\/nrendo.2015.122.","DOI":"10.1038\/nrendo.2015.122"},{"key":"2516_CR24","doi-asserted-by":"publisher","unstructured":"Zhang H, Zhu K, Zhang R, Guo Y, Wang J, Liu C, Lu X, Zhou Z, Wu W, Zhang F, Song Z, Lin S, Yang C, Li X, Liu Y, Tang Q, Yu X, Xu L, Liu C. Oleic acid-PPAR\u03b3-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment. Hepatol Baltim Md 2024;80:69\u201386. https:\/\/doi.org\/10.1097\/HEP.0000000000000784.","DOI":"10.1097\/HEP.0000000000000784"},{"key":"2516_CR25","doi-asserted-by":"publisher","unstructured":"Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12\/15-lipoxygenase. Nature 1999;400:378\u201382. https:\/\/doi.org\/10.1038\/22572.","DOI":"10.1038\/22572"},{"key":"2516_CR26","doi-asserted-by":"publisher","unstructured":"Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 1998;93:229\u201340. https:\/\/doi.org\/10.1016\/s0092-8674(00)81574-3.","DOI":"10.1016\/s0092-8674(00)81574-3"},{"key":"2516_CR27","doi-asserted-by":"publisher","unstructured":"Shinoda Y, Wang Y, Yamamoto T, Miyachi H, Fukunaga K. Analysis of binding affinity and docking of novel fatty acid-binding protein (FABP) ligands. J Pharmacol Sci 2020;143:264\u201371. https:\/\/doi.org\/10.1016\/j.jphs.2020.05.005.","DOI":"10.1016\/j.jphs.2020.05.005"},{"key":"2516_CR28","doi-asserted-by":"publisher","unstructured":"Picard FSR, Lutz V, Brichkina A, Neuhaus F, Ruckenbrod T, Hupfer A, Raifer H, Klein M, Bopp T, Pfefferle PI, Savai R, Prinz I, Waisman A, Moos S, Chang H-D, Heinrich S, Bartsch DK, Buchholz M, Singh S, Tu M, Klein L, Bauer C, Liefke R, Burchert A, Chung H-R, Mayer P, Gress TM, Lauth M, Gaida M, Huber M. IL-17A-producing CD8\u2009+\u2009T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts. Gut 2023;72:1510\u201322. https:\/\/doi.org\/10.1136\/gutjnl-2022-327855.","DOI":"10.1136\/gutjnl-2022-327855"},{"key":"2516_CR29","doi-asserted-by":"publisher","unstructured":"Meng Y, Ye F, Nie P, Zhao Q, An L, Wang W, Qu S, Shen Z, Cao Z, Zhang X, Jiao S, Wu D, Zhou Z, Wei L. Immunosuppressive CD10\u2009+\u2009ALPL\u2009+\u2009neutrophils promote resistance to anti-PD-1 therapy in HCC by mediating irreversible exhaustion of T cells. J Hepatol 2023:S0168-8278(23)05078-X. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.024.","DOI":"10.1016\/j.jhep.2023.08.024"},{"key":"2516_CR30","doi-asserted-by":"publisher","unstructured":"Ding S, Lin Z, Zhang X, Jia X, Li H, Fu Y, Wang X, Zhu G, Lu G, Xiao W, Gong W. Deficiency of angiopoietin-like 4 enhances CD8+ T cell bioactivity via metabolic reprogramming for impairing tumour progression. Immunology 2023;170:28\u201346. https:\/\/doi.org\/10.1111\/imm.13650.","DOI":"10.1111\/imm.13650"},{"key":"2516_CR31","doi-asserted-by":"publisher","unstructured":"Bajwa P, Kordylewicz K, Bilecz A, Lastra RR, Wroblewski K, Rinkevich Y, Lengyel E, Kenny HA. Cancer-associated mesothelial cell-derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis. JCI Insight 2023;8:e163019. https:\/\/doi.org\/10.1172\/jci.insight.163019.","DOI":"10.1172\/jci.insight.163019"},{"key":"2516_CR32","doi-asserted-by":"publisher","unstructured":"Chaube B, Citrin KM, Sahraei M, Singh AK, de Urturi DS, Ding W, Pierce RW, Raaisa R, Cardone R, Kibbey R, Fern\u00e1ndez-Hernando C, Su\u00e1rez Y. Suppression of angiopoietin-like 4 reprograms endothelial cell metabolism and inhibits angiogenesis. Nat Commun 2023;14:8251. https:\/\/doi.org\/10.1038\/s41467-023-43900-0.","DOI":"10.1038\/s41467-023-43900-0"},{"key":"2516_CR33","doi-asserted-by":"publisher","unstructured":"Zhang S, Zhang N, Wan T, He Y, Hao J, Liu Y, Liu Y, Chen B, Zhao W, Wang L, Luo D, Gao C, Yang Q. Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO\/m6A\/ANGPTL4\/integrin axis in triple-negative breast cancer. J Exp Clin Cancer Res CR 2025;44:41. https:\/\/doi.org\/10.1186\/s13046-025-03282-1.","DOI":"10.1186\/s13046-025-03282-1"},{"key":"2516_CR34","doi-asserted-by":"publisher","unstructured":"Zhao R, Pan Z, Qiu J, Li B, Qi Y, Gao Z, Qiu W, Tang W, Guo X, Deng L, Li G, Xue H. Blocking ITGA5 potentiates the efficacy of anti-PD-1 therapy on glioblastoma by remodeling tumor-associated macrophages. Cancer Commun Lond Engl 2025;45:677\u2013701. https:\/\/doi.org\/10.1002\/cac2.70016.","DOI":"10.1002\/cac2.70016"},{"key":"2516_CR35","doi-asserted-by":"publisher","unstructured":"Cao T, Zhang W, Wang Q, Wang C, Ma W, Zhang C, Ge M, Tian M, Yu J, Jiao A, Wang L, Liu M, Wang P, Guo Z, Zhou Y, Chen S, Yin W, Yi J, Guo H, Han H, Zhang B, Wu K, Fan D, Wang X, Nie Y, Lu Y, Zhao X. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8\u2009+\u2009T cells. Cell 2024;187:2288\u20132304.e27. https:\/\/doi.org\/10.1016\/j.cell.2024.03.011.","DOI":"10.1016\/j.cell.2024.03.011"},{"key":"2516_CR36","doi-asserted-by":"publisher","unstructured":"Aj D, J S, L F, D W, Ld D, Jf C. Antioxidant and Anti-Tumor Effects of Dietary Vitamins A, C, and E. Antioxid Basel Switz 2023;12. https:\/\/doi.org\/10.3390\/antiox12030632.","DOI":"10.3390\/antiox12030632"},{"key":"2516_CR37","doi-asserted-by":"publisher","unstructured":"Wallert M, Schm\u00f6lz L, Galli F, Birringer M, Lorkowski S. Regulatory metabolites of vitamin E and their putative relevance for atherogenesis. Redox Biol 2014;2:495\u2013503. https:\/\/doi.org\/10.1016\/j.redox.2014.02.002.","DOI":"10.1016\/j.redox.2014.02.002"},{"key":"2516_CR38","doi-asserted-by":"publisher","unstructured":"Gill J, Gorlick R. Advancing therapy for osteosarcoma. Nat Rev Clin Oncol 2021;18:609\u201324. https:\/\/doi.org\/10.1038\/s41571-021-00519-8.","DOI":"10.1038\/s41571-021-00519-8"},{"key":"2516_CR39","doi-asserted-by":"publisher","unstructured":"Jin H-R, Wang J, Wang Z-J, Xi M-J, Xia B-H, Deng K, Yang J-L. Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics. J Hematol OncolJ Hematol Oncol 2023;16:103. https:\/\/doi.org\/10.1186\/s13045-023-01498-2.","DOI":"10.1186\/s13045-023-01498-2"},{"key":"2516_CR40","doi-asserted-by":"publisher","unstructured":"Gong J, Lin Y, Zhang H, Liu C, Cheng Z, Yang X, Zhang J, Xiao Y, Sang N, Qian X, Wang L, Cen X, Du X, Zhao Y. Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells. Cell Death Dis 2020;11:267. https:\/\/doi.org\/10.1038\/s41419-020-2434-z.","DOI":"10.1038\/s41419-020-2434-z"},{"key":"2516_CR41","doi-asserted-by":"publisher","unstructured":"Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct Target Ther 2021;6:72. https:\/\/doi.org\/10.1038\/s41392-020-00449-4.","DOI":"10.1038\/s41392-020-00449-4"},{"key":"2516_CR42","doi-asserted-by":"publisher","unstructured":"Z W. Vitamin E boosts immunotherapy. Nat Cell Biol 2022;24. https:\/\/doi.org\/10.1038\/s41556-022-00979-9.","DOI":"10.1038\/s41556-022-00979-9"},{"key":"2516_CR43","doi-asserted-by":"publisher","unstructured":"X Y, Y D, Y X, K S, Y Q, Y Z, Z A, D M, J Y, H L, L Z, Ae Y, P L, C Z, A B-N, Y S, X L, Wl K, H Y, Sc S, Jc C, Ja T, D Y. Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1. Cancer Discov 2022;12.https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0900.","DOI":"10.1158\/2159-8290.CD-21-0900"},{"key":"2516_CR44","doi-asserted-by":"publisher","unstructured":"He S, Zheng L, Qi C. Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy. Mol Cancer 2025;24:5. https:\/\/doi.org\/10.1186\/s12943-024-02208-3.","DOI":"10.1186\/s12943-024-02208-3"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02516-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02516-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:42:59Z","timestamp":1769168579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02516-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2516"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02516-2","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This protocol was developed to be consistent with the ethical principle described in the Helsinki Declaration and received consent from the Ethical Review Committees of SYSUCC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}